| Amy Marie Villaret, PA | |
|
925 Tahoe Blvd Ste 105, Incline Village, NV 89451-7498 | |
| (775) 580-7600 | |
| (775) 831-0946 |
| Full Name | Amy Marie Villaret |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 925 Tahoe Blvd Ste 105, Incline Village, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255638870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA1281 (Nevada) | Primary |
| 363A00000X | Physician Assistant | PA21440 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barton Memorial Hospital | South lake tahoe, CA | Hospital |
| Carson Valley Medical Center | Gardnerville, NV | Hospital |
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tahoe Orthopedics And Sports Medicine, Inc. | 9537203351 | 15 |
| Lake Tahoe Orthopaedic Institute A Watson-swanson Professional Corp | 3375448384 | 18 |
News Archive
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders including obesity, has presented the results of a preclinical study that further supports the Company's understanding of an aspect of the mechanism of action of Contrave, one of its two late-stage obesity drug candidates.
Unlike most home healthcare agencies, which have restricted the use of computer programs to such non-patient-care items as billing, the Visiting Nurse Service of New York has adopted advanced information technology in order to improve patient care. One of the results, documented in a new publication, is a significant 10% reduction in patient episodes ending in hospitalization, from 37% to 27% over the years 2001-2009.
Announcing a new article publication for BIO Integration journal. In this review article the authors Yue Li, Zhiyi Chen and Shuping Ge from First Affiliated Hospital of University of South China, Hengyang, China and Tower Health and Drexel University, Philadelphia, PA, USA summarize current state of the art applications of microbubble-cell interactions and sonoporation effects to cellular functions.
EpiCept Corporation today announced that it received a refusal to file letter from the U.S. Food and Drug Administration (FDA) on the New Drug Application (NDA) for Ceplene(histamine dihydrochloride).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Marie Villaret, PA 1111 Emerald Bay Rd, South Lake Tahoe, CA 96150-6207 Ph: (530) 543-5659 | Amy Marie Villaret, PA 925 Tahoe Blvd Ste 105, Incline Village, NV 89451-7498 Ph: (775) 580-7600 |
News Archive
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders including obesity, has presented the results of a preclinical study that further supports the Company's understanding of an aspect of the mechanism of action of Contrave, one of its two late-stage obesity drug candidates.
Unlike most home healthcare agencies, which have restricted the use of computer programs to such non-patient-care items as billing, the Visiting Nurse Service of New York has adopted advanced information technology in order to improve patient care. One of the results, documented in a new publication, is a significant 10% reduction in patient episodes ending in hospitalization, from 37% to 27% over the years 2001-2009.
Announcing a new article publication for BIO Integration journal. In this review article the authors Yue Li, Zhiyi Chen and Shuping Ge from First Affiliated Hospital of University of South China, Hengyang, China and Tower Health and Drexel University, Philadelphia, PA, USA summarize current state of the art applications of microbubble-cell interactions and sonoporation effects to cellular functions.
EpiCept Corporation today announced that it received a refusal to file letter from the U.S. Food and Drug Administration (FDA) on the New Drug Application (NDA) for Ceplene(histamine dihydrochloride).
› Verified 8 days ago
Virginia Murnane, R.N. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 547 Dale Dr, Incline Village, NV 89451 Phone: 775-832-8481 | |
Christel Marshall, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 889 Alder Ave Ste 203, Incline Village, NV 89451 Phone: 775-832-5200 | |
Samantha Brooks Wood Smith, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 889 Alder Ave, #203, Incline Village, NV 89451 Phone: 775-832-5200 Fax: 775-832-5205 |